Benzinga | Aug 7, 2020 04:32PM EDT

Denali Therapeutics Q2 EPS $(0.56) Up From $(0.61) YoY, Sales $5.85M Up From $4.20M YoY

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.56) per share. This is a 8.2 percent increase over losses of $(0.61) per share from the same period last year. The company reported $5.85 million in sales this quarter. This is a 39.31 percent increase over sales of $4.20 million the same period last year.